Esplenomegalia como signo de enfermedad lisosomal

Autores/as

DOI:

https://doi.org/10.24197/aramcv.56.2020.400-414

Palabras clave:

Bazo, enfermedad de Gaucher, enfermedad de depósito lisosomial

Resumen

La estructura sana del bazo funciona como función hematopoyética para el período fetal; después, se convierte en un gran órgano linfoide, y también, es del sistema de filtro de células sanguíneas.

La enfermedad de Gaucher es un extraño trastorno de almacenamiento lisosomal, muchos de ellos son hereditarios y multisistémicos. Hoy en día, setenta LSD han sido adoptados.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Baudelaire C. El spleen de París (pequeños poemas en prosa). Ed. Susaeta, 1994.

Dacie JV, Brain MC, Harrison CV et al. Non-tropical splenomegaly (“primary hypersplenism”) a review of ten cases and their relationship to malignant lymphomas. Br J haematol 1969; 17: 317.

O'Reilly RA. Splenomegaly in 2505 Patients at a Large University Medical Center From 1913 to 1995. The Western Journal of Medicine 1998; 169:88-97.

Curovic Rotbain E, Lund Hansen D, Schaffalitzky de Muckadell O et al. Splenomegaly-diagnostic validity, work-up, and underlying causes. PloS One 2017; 12:e0186674.

Motta I, Filocamo M, Poggiali E et al. a multicenter observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia. European Journal of Haematology 2016; 96:352-359.

Sills R.H., Hochberg Z. (eds): Practical Algorithms in Pediatric Hematology and Oncology. Basel, Karger, 2003, pp 50-51. doi: 10.1159/000069597.

Chapman J, Azevedo AM. Splenomegaly. [Updated 2019 May 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430907/.

Platt FM, d´Azzo A, Davidson BL et al. Lysosomal storage diseases. Nature Reviews Disease Primers 2018; 4:27.

Platt FM. Nature Reviews Drug Discovery 2018; 17:133-150.

Grabowski GA. Phenotype, diagnosis and treatment of Gaucher´s disease. Lancet 2008; 372:1263-1271.

Schuchman EH & Wasserstein MP. Types A and B Niemann-Pick disease. Best practice & research Clinical endocrinology & metabolism 2015; 29:237-247.

Schuchman EH & Desnick RJ. Types A and B Niemann-Molecular genetics and metabolism 2017; 120:27-33.

Kaplan P, Andersson HC, Kacena KA et al. The clinical and demographic characteristics of nonneuropathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 2006; 160: 603-608.

Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000; 160(18):2835-2843.

Grawoski GA, Andria G, Baldello A, et al. Pediatric non-neuronopathic Gaucher disease, presentation, diagnosis and assessment. Consensus statements. Eur J Pediatr 2004; 163: 58-66.

Mc Govern MM, Aron A, Brodie SE et al. Natural history of type A Niemann-Pick disease: possible endpoints for therapeutic trials. Neurology 2006; 66: 228-232.

Wasserstein MP, Desnick RJ, Schuchman EH, et al. The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study. Pediatrics 2004; 114: e672-e677.

Thurberg BL, Wasserstein MP, Schlano T. Liver and skin histopathology in adults with sphingomyelinase deficiency (Niemann-Pck disease typeB). Am J Surg Pathol. 2012;36:1234-1246

Guillemot N, Troadec C, de Villemeur TB, et al. Lung disease in Niemann-Pick disease. Pediatr Pulmonol 2007; 42: 1207-1214.

McGovern, MM, Pohl-Worgall T, Deckelbaum RJ, .et al. Lipid abnormalities in children with types A and B Niemann-Pick disease. J Pediatr 2004;145:77-81.

Di Rocco M, Andria G, Deodato F, et al. Early diagnosis of Gaucher disease in pediatric patients: proposal for a diagnostic algorithm. Pediatric blood & cancer. 2014;61:1905-1909.

Mistry PK, Capellini MD, Lukina E. A reappraisal of Gaucher disease-diagnosis and disease management algorithm. American Journal of Hematology 2011; 86:110-115.

McGovern MM, Dionisi C, Giugliani B et al. Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency. Genetics in Medicine 2017; 19:967-974.

Descargas

Publicado

11/09/2023

Cómo citar

García Frade, L. J., Campano García, A., & Villarubia, J. (2023). Esplenomegalia como signo de enfermedad lisosomal. ANALES DE LA REAL ACADEMIA DE MEDICINA Y CIRUGÍA DE VALLADOLID, (56), 400–414. https://doi.org/10.24197/aramcv.56.2020.400-414

Número

Sección

Artículos